TrialClinical lung cancer2015

Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients.

Erin M Bertino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.